Abstract
Twelve parotid incidentalomas in 10 consecutive subjects (nine with a known malignancy elsewhere and one presumptively healthy subject) identified by combined 18F-fluorodeoxyglucose whole-body positron emission tomography and computed tomography (18F-FDG PET/CT) were investigated, with the aim of calculating maximum standardized uptake value (SUVmax) of each FDG-avid focus, and identifying corresponding sonographic and pathologic findings. The results of ultrasound-guided fine-needle aspiration biopsy (FNAB) (n = 9) and core-needle biopsy (CNB) (n = 3) were Warthin tumor in 10 cases, and pleomorphic adenoma and chronic inflammation in one each. SUVmax was 7.0–21.0 g/mL (average 13.7 g/mL) for Warthin tumor, 6.8 g/mL for pleomorphic adenoma, and 7.3 g/mL for chronic inflammation. Each FDG-avid focus corresponded to ovoid (n = 11) or lobulated (n = 1) hypoechoic mass on grayscale ultrasonography (US) and hypervascular mass, except one with chronic inflammation, on power Doppler (PD) US. Parotid incidentaloma identified by 18F-FDG PET/CT during workup of various malignancies elsewhere does not necessarily signify primary or metastatic malignancy, but indicates a high likelihood of benign lesions, particularly Warthin tumor. Such lesions should be evaluated thoroughly by US and ultrasound-guided FNAB or CNB if parotid disease would change the patient’s treatment plan.
Similar content being viewed by others
References
Keyes JW Jr, Watson NE Jr, Williams DW 3rd, Greven KM, McGuirt WF (1997) FDG PET in head and neck cancer. AJR Am J Roentgenol 169:1663–1669
Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, Altman H, Keidar Z, Israel O (2003) Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 44:1200–1209
Kluetz PG, Meltzer CC, Villemagne VL, Kinahan PE, Chander S, Martinelli MA, Townsend DW (2000) Combined PET/CT imaging in oncology. Impact on patient management. Clin Positron Imaging 3:223–230
Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman RE, Wahl R, Paschold JC, Avril N, Einhorn LH, Suh WW, Samson D, Delbeke D, Gorman M, Shields AF (2008) Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 49:480–508
Keyes JW Jr, Harkness BA, Greven KM, Williams DW 3rd, Watson NE Jr, McGuirt WF (1994) Salivary gland tumor: pretherapy evaluation with PET. Radiology 192:99–102
Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T, Uno T, Okamoto Y, Ito H (2005) Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Clin Nucl Med 30:170–176
Shimizu M, Ussmüller J, Hartwein J, Donath K, Kinukawa N (1999) Statistical study for sonographic differential diagnosis of tumorous lesions in the parotid gland. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:226–233
Zajkowski P, Jakubowski W, Białek EJ, Wysocki M, Osmólski A, Serafin-Król M (2000) Pleomorphic adenoma and adenolymphoma in ultrasonography. Eur J Ultrasound 12:23–29
Gritzmann N (1989) Sonography of the salivary glands. AJR Am J Roentgenol 153:161–166
Cvetinović M, Jović N, Mijatović D (1991) Evaluation of ultrasound in the diagnosis of pathologic processes in the parotid gland. J Oral Maxillofac Surg 49:147–150
Schick S, Steiner E, Gahleitner A, Böhm P, Helbich T, Ba-Ssalamah A, Mostbeck G (1998) Differentiation of benign and malignant tumors of the parotid gland: value of pulsed Doppler and color Doppler sonography. Eur Radiol 8:1462–1467
Van den Bruel A, Maes A, De Potter T, Mortelmans L, Drijkoningen M, Van Damme B, Delaere P, Bouillon R (2002) Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab 87:1517–1520
King DL, Stack BC Jr, Spring PM, Walker R, Bodenner DL (2007) Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngol Head Neck Surg 137:400–404
Horiuchi M, Yasuda S, Shohtsu A, Ide M (1998) Four cases of Warthin’s tumor of the parotid gland detected with FDG PET. Ann Nucl Med 12:47–50
Rubello D, Nanni C, Castellucci P, Rampin L, Farsad M, Franchi R, Mariani G, Menaldo G, Fanti S (2005) Does 18F-FDG PET/CT play a role in the differential diagnosis of parotid masses. Panminerva Med 47:187–189
Basu S, Houseni M, Alavi A (2008) Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management. Nucl Med Commun 29:367–373
Wittich GR, Scheible WF, Hajek PC (1985) Ultrasonography of the salivary glands. Radiol Clin North Am. 23:29–37
Renehan A, Gleave EN, Hancock BD, Smith P, McGurk M (1996) Long-term follow-up of over 1000 patients with salivary gland tumours treated in a single centre. Br J Surg 83:1750–1754
Okamura T, Kawabe J, Koyama K, Ochi H, Yamada R, Sakamoto H, Matsuda M, Ohashi Y, Nakai Y (1998) Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions. Acta Otolaryngol Suppl 538:209–213
Bialek EJ, Jakubowski W, Zajkowski P, Szopinski KT, Osmolski A (2006) US of the major salivary glands: anatomy and spatial relationships, pathologic conditions, and pitfalls. Radiographics 26:745–763
Kim J, Kim EK, Park CS, Choi YS, Kim YH, Choi EC (2004) Characteristic sonographic findings of Warthin's tumor in the parotid gland. J Clin Ultrasound 32:78–81
Wong DS, Li GK (2000) The role of fine-needle aspiration cytology in the management of parotid tumors: a critical clinical appraisal. Head Neck 22:469–473
Stewart CJ, MacKenzie K, McGarry GW, Mowat A (2000) Fine-needle aspiration cytology of salivary gland: a review of 341 cases. Diagn Cytopathol 22:139–146
Bartels S, Talbot JM, DiTomasso J, Everts EC, Andersen PE, Wax MK, Cohen JI (2000) The relative value of fine-needle aspiration and imaging in the preoperative evaluation of parotid masses. Head Neck 22:781–786
Zbären P, Schär C, Hotz MA, Loosli H (2001) Value of fine-needle aspiration cytology of parotid gland masses. Laryngoscope 111:1989–1992
Wan YL, Chan SC, Chen YL, Cheung YC, Lui KW, Wong HF, Hsueh C, See LC (2004) Ultrasonography-guided core-needle biopsy of parotid gland masses. AJNR Am J Neuroradiol 25:1608–1612
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, S.K., Rho, B.H. & Won, K.S. Parotid incidentaloma identified by combined 18F-fluorodeoxyglucose whole-body positron emission tomography and computed tomography: findings at grayscale and power Doppler ultrasonography and ultrasound-guided fine-needle aspiration biopsy or core-needle biopsy. Eur Radiol 19, 2268–2274 (2009). https://doi.org/10.1007/s00330-009-1407-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-009-1407-5